ID: ALA321209

Max Phase: Preclinical

Molecular Formula: C43H63N7O10S2

Molecular Weight: 902.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCNC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CCSC)NC=O

Standard InChI:  InChI=1S/C43H63N7O10S2/c1-28(2)24-34(40(55)48-35(41(56)57)25-29-14-8-6-9-15-29)47-39(54)33(20-23-62-5)50-43(59)44-21-13-12-18-32(46-37(52)31(45-27-51)19-22-61-4)38(53)49-36(42(58)60-3)26-30-16-10-7-11-17-30/h6-11,14-17,27-28,31-36H,12-13,18-26H2,1-5H3,(H,45,51)(H,46,52)(H,47,54)(H,48,55)(H,49,53)(H,56,57)(H2,44,50,59)/t31-,32-,33-,34-,35-,36-/m0/s1

Standard InChI Key:  BRZGOLNIMKBTRR-NGTAMTFRSA-N

Associated Targets(Human)

Superoxide dismutase 173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lysozyme C 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 902.15Molecular Weight (Monoisotopic): 901.4078AlogP: 2.17#Rotatable Bonds: 30
Polar Surface Area: 250.23Molecular Species: ACIDHBA: 11HBD: 8
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.99CX Basic pKa: CX LogP: 2.68CX LogD: -0.48
Aromatic Rings: 2Heavy Atoms: 62QED Weighted: 0.03Np Likeness Score: -0.19

References

1. Cavicchioni G, Turchetti M, Spisani S..  (2001)  Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.,  11  (24): [PMID:11720864] [10.1016/s0960-894x(01)00640-0]

Source